Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Agreement signed with Nephromics for preeclampsia test
September 8th, 2005
Abbott has entered into a licensing agreement with Nephromics LLC, a Chestnut Hill, Massachusetts, company, for patents related to the development of in vitro diagnostic tests to detect preeclampsia. Currently, no specific diagnostic test exists to detect this life-threatening disease that affects the health of thousands of pregnant women each year. "Because preeclampsia can strike quickly, potentially causing severe and immediate complications such as seizures and organ failure that threaten both the health of the baby and mother unless the pregnancy is induced, early diagnostic tests are needed," said David Barch, MD, medical director, Abbott...
Source: Women's Health Weekly (2005-09-08)
|
